Trials and PIs
View all posts »Prescription Omega-3-Acid Ethyl Esters (P-OM3) for the Prevention of Recurrent Symptomatic Atrial Fibrillation (AF) with Dr Peter Kowey
Nov 15, 2010 15:09 EST-
1Comments
-
Read later
Dr Peter Kowey (Main Line Health Heart Center Lankenau Hospital, Wynnewood, PA) discusses Efficacy and Safety of Prescription Omega-3-Acid Ethyl Esters (P-OM3) for the Prevention of Recurrent Symptomatic Atrial Fibrillation (AF) with Dr Gabriel Steg.
Filmed during AHA 2010 in Chicago, IL on November 14.
See:
Omega-3 PUFA caps don't suppress paroxysmal AF in randomized trial
Your comments
 |
 |
 |
||
 |
|
 |
||
 |
 |
 |
||
 |
|
|
 |
|
 |
 |
 |
||
 |
|
|
 |
|
|
|
|
||
|
||||
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!
